Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group.
Zatelli MC, Faggiano A, Argentiero A, Danesi R, D'Oronzo S, Fogli S, Franchina T, Giorgino F, Marrano N, Giuffrida D, Gori S, Marino G, Mazzilli R, Monami M, Montagnani M, Morviducci L, Natalicchio A, Ragni A, Renzelli V, Russo A, Sciacca L, Tuveri E, Aimaretti G, Avogaro A, Candido R, Di Maio M, Silvestris N, Gallo M. Zatelli MC, et al. Among authors: di maio m. Cancer Treat Rev. 2024 May;126:102734. doi: 10.1016/j.ctrv.2024.102734. Epub 2024 Apr 3. Cancer Treat Rev. 2024. PMID: 38604051 Free article. Review.
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM).
Pedrazzoli P, Lasagna A, Cassaniti I, Piralla A, Squeri A, Bruno R, Sacchi P, Baldanti F, Di Maio M, Beretta GD, Cinieri S, Silvestris N. Pedrazzoli P, et al. Among authors: di maio m. ESMO Open. 2023 Jun;8(3):101215. doi: 10.1016/j.esmoop.2023.101215. Epub 2023 Apr 3. ESMO Open. 2023. PMID: 37104930 Free PMC article. Review.
Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial Cancer.
Gamba T, Paparo J, Panepinto O, Dionisio R, Di Maio M, Vignani F. Gamba T, et al. Among authors: di maio m. Clin Genitourin Cancer. 2023 Oct;21(5):509-516. doi: 10.1016/j.clgc.2023.07.009. Epub 2023 Jul 20. Clin Genitourin Cancer. 2023. PMID: 37500375 Free article. Review.
Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology.
Leone AG, Miceli R, Trapani D, Massagrande M, Morano F, Marsoni S, La Verde N, Berardi R, Casolino R, Lambertini M, Dalu D, Di Maio M, Beretta GD, Perrone F, Cinieri S, Pietrantonio F. Leone AG, et al. Among authors: di maio m. ESMO Open. 2023 Jun;8(3):101578. doi: 10.1016/j.esmoop.2023.101578. Epub 2023 Jun 2. ESMO Open. 2023. PMID: 37270870 Free PMC article.
Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations.
Leone AG, Casolino R, Trapani D, Miceli R, Massagrande M, Morano F, La Verde N, Dalu D, Berardi R, Marsoni S, Lambertini M, Iula B, Carieri E, Converti M, Di Maio M, Beretta GD, Perrone F, Pietrantonio F, Cinieri S; Italian Foundation of Medical Oncology (Fondazione AIOM); Italian Association of Medical Oncology (AIOM). Leone AG, et al. Among authors: di maio m. EClinicalMedicine. 2023 Oct 17;65:102277. doi: 10.1016/j.eclinm.2023.102277. eCollection 2023 Nov. EClinicalMedicine. 2023. PMID: 37877000 Free PMC article. Review.
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis.
Anpalakhan S, Signori A, Cortellini A, Verzoni E, Giusti R, Aprile G, Ermacora P, Catino A, Pipitone S, Di Napoli M, Scotti V, Mazzoni F, Guglielmini PF, Veccia A, Maruzzo M, Schinzari G, Casadei C, Grossi F, Rizzo M, Montesarchio V, Verderame F, Mencoboni M, Zustovich F, Fratino L, Accettura C, Cinieri S, Tondini CA, Camerini A, Banzi MC, Sorarù M, Zucali PA, Vignani F, Ricciardi S, Russo A, Cosenza A, Di Maio M, De Giorgi U, Pignata S, Giannarelli D, Pinto C, Buti S, Fornarini G, Rebuzzi SE, Rescigno P, Addeo A, Banna GL, Bersanelli M. Anpalakhan S, et al. Among authors: di maio m, di napoli m. iScience. 2023 Sep 22;26(11):107970. doi: 10.1016/j.isci.2023.107970. eCollection 2023 Nov 17. iScience. 2023. PMID: 37860695 Free PMC article.
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial.
Napolitano S, Ciardiello D, De Falco V, Martini G, Martinelli E, Della Corte CM, Esposito L, Famiglietti V, Di Liello A, Avallone A, Cardone C, De Stefano A, Montesarchio V, Zampino MG, Fazio N, Di Maio M, Del Tufo S, De Vita F, Altucci L, Marrone F, Ciardiello F, Troiani T. Napolitano S, et al. Among authors: di maio m, di liello a. Int J Cancer. 2023 Oct 15;153(8):1520-1528. doi: 10.1002/ijc.34632. Epub 2023 Jun 30. Int J Cancer. 2023. PMID: 37391938 Clinical Trial.
Osimertinib in Resected EGFR-Mutated NSCLC.
Di Maio M. Di Maio M. N Engl J Med. 2023 Oct 5;389(14):1341-1342. doi: 10.1056/NEJMc2309385. N Engl J Med. 2023. PMID: 37792622 No abstract available.
Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors.
Delcuratolo MD, Tucci M, Turco F, Di Stefano RF, Ungaro A, Audisio M, Samuelly A, Brusa F, Audisio A, Di Maio M, Scagliotti GV, Buttigliero C. Delcuratolo MD, et al. Among authors: di stefano rf, di maio m. Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24. Crit Rev Oncol Hematol. 2023. PMID: 36427772 Review.
634 results